These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 11085541)

  • 1. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
    Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E
    Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
    Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines.
    Medina PP; Romero OA; Kohno T; Montuenga LM; Pio R; Yokota J; Sanchez-Cespedes M
    Hum Mutat; 2008 May; 29(5):617-22. PubMed ID: 18386774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.
    Reisman DN; Sciarrotta J; Wang W; Funkhouser WK; Weissman BE
    Cancer Res; 2003 Feb; 63(3):560-6. PubMed ID: 12566296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
    Rodriguez-Nieto S; Sanchez-Cespedes M
    Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
    Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
    Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation.
    Banine F; Bartlett C; Gunawardena R; Muchardt C; Yaniv M; Knudsen ES; Weissman BE; Sherman LS
    Cancer Res; 2005 May; 65(9):3542-7. PubMed ID: 15867346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian chromatin remodeling complex SWI/SNF is essential for enhanced expression of the albumin gene during liver development.
    Inayoshi Y; Miyake K; Machida Y; Kaneoka H; Terajima M; Dohda T; Takahashi M; Iijima S
    J Biochem; 2006 Feb; 139(2):177-88. PubMed ID: 16452305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When the SWI/SNF complex remodels...the cell cycle.
    Muchardt C; Yaniv M
    Oncogene; 2001 May; 20(24):3067-75. PubMed ID: 11420722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.
    Decristofaro MF; Betz BL; Rorie CJ; Reisman DN; Wang W; Weissman BE
    J Cell Physiol; 2001 Jan; 186(1):136-45. PubMed ID: 11147808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
    Rosson GB; Bartlett C; Reed W; Weissman BE
    J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the BRG1 gene in prostate cancer clinical samples.
    Valdman A; Nordenskjöld A; Fang X; Naito A; Al-Shukri S; Larsson C; Ekman P; Li C
    Int J Oncol; 2003 May; 22(5):1003-7. PubMed ID: 12684665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
    Tu N; Hu Y; Mivechi NF
    J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations of BRG1 leads to cancer development through its nuclear-cytoplasmic shuttling abnormalities.
    Gunduz E; Gunduz M; Nagatsuka H; Beder L; Demircan K; Tamamura R; Hatipoglu OF; Mahmut N; Katase N; Naomoto Y; Nagai N
    Med Hypotheses; 2006; 67(6):1313-6. PubMed ID: 16824695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
    Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
    Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.